nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—ovarian cancer	0.712	1	CbGaD
Glucosamine—NFKB2—myometrium—ovarian cancer	0.00771	0.0909	CbGeAlD
Glucosamine—NFKB2—uterine cervix—ovarian cancer	0.006	0.0708	CbGeAlD
Glucosamine—NFKB2—decidua—ovarian cancer	0.00571	0.0674	CbGeAlD
Glucosamine—NFKB2—female reproductive system—ovarian cancer	0.00449	0.053	CbGeAlD
Glucosamine—TNF—vagina—ovarian cancer	0.00412	0.0487	CbGeAlD
Glucosamine—IFNG—epithelium—ovarian cancer	0.0041	0.0484	CbGeAlD
Glucosamine—NFKB2—female gonad—ovarian cancer	0.00409	0.0482	CbGeAlD
Glucosamine—NFKB2—testis—ovarian cancer	0.00363	0.0428	CbGeAlD
Glucosamine—IFNG—uterus—ovarian cancer	0.00339	0.04	CbGeAlD
Glucosamine—MMP9—embryo—ovarian cancer	0.00323	0.0381	CbGeAlD
Glucosamine—IFNG—female reproductive system—ovarian cancer	0.00305	0.0359	CbGeAlD
Glucosamine—IFNG—bone marrow—ovarian cancer	0.00288	0.0339	CbGeAlD
Glucosamine—IFNG—vagina—ovarian cancer	0.00276	0.0325	CbGeAlD
Glucosamine—TNF—lymph node—ovarian cancer	0.00267	0.0315	CbGeAlD
Glucosamine—MMP9—epithelium—ovarian cancer	0.00263	0.0311	CbGeAlD
Glucosamine—NFKB2—lymph node—ovarian cancer	0.00263	0.031	CbGeAlD
Glucosamine—MMP9—uterine cervix—ovarian cancer	0.00261	0.0308	CbGeAlD
Glucosamine—MMP9—decidua—ovarian cancer	0.00249	0.0293	CbGeAlD
Glucosamine—MMP9—endometrium—ovarian cancer	0.00236	0.0279	CbGeAlD
Glucosamine—MMP9—uterus—ovarian cancer	0.00218	0.0257	CbGeAlD
Glucosamine—MMP9—female reproductive system—ovarian cancer	0.00196	0.0231	CbGeAlD
Glucosamine—MMP9—bone marrow—ovarian cancer	0.00185	0.0218	CbGeAlD
Glucosamine—IFNG—lymph node—ovarian cancer	0.00178	0.021	CbGeAlD
Glucosamine—MMP9—female gonad—ovarian cancer	0.00178	0.021	CbGeAlD
Glucosamine—MMP9—testis—ovarian cancer	0.00158	0.0186	CbGeAlD
Glucosamine—MMP9—lymph node—ovarian cancer	0.00114	0.0135	CbGeAlD
Glucosamine—CYP2C19—vagina—ovarian cancer	0.000793	0.00936	CbGeAlD
Glucosamine—CYP2E1—female reproductive system—ovarian cancer	0.000644	0.0076	CbGeAlD
Glucosamine—CYP2E1—testis—ovarian cancer	0.00052	0.00614	CbGeAlD
Glucosamine—Streptozocin—ABCB1—ovarian cancer	0.000181	1	CrCbGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—MAPK1—ovarian cancer	5.8e-05	0.000285	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—ovarian cancer	5.79e-05	0.000284	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—ovarian cancer	5.78e-05	0.000284	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—HRAS—ovarian cancer	5.74e-05	0.000282	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PIK3CB—ovarian cancer	5.71e-05	0.000281	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MTOR—ovarian cancer	5.71e-05	0.000281	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—ovarian cancer	5.65e-05	0.000278	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MAPK3—ovarian cancer	5.64e-05	0.000277	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—ovarian cancer	5.64e-05	0.000277	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CASP3—ovarian cancer	5.62e-05	0.000276	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	5.58e-05	0.000274	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	5.51e-05	0.000271	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MET—ovarian cancer	5.5e-05	0.000271	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—ovarian cancer	5.5e-05	0.00027	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—ovarian cancer	5.49e-05	0.00027	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—KRAS—ovarian cancer	5.47e-05	0.000269	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—STAT3—ovarian cancer	5.47e-05	0.000269	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CTNNB1—ovarian cancer	5.45e-05	0.000268	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	5.42e-05	0.000266	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6ST—ovarian cancer	5.39e-05	0.000265	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—AKT1—ovarian cancer	5.39e-05	0.000265	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MAPK1—ovarian cancer	5.37e-05	0.000264	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—ovarian cancer	5.37e-05	0.000264	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1B—ovarian cancer	5.36e-05	0.000263	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP3—ovarian cancer	5.3e-05	0.000261	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	5.27e-05	0.000259	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—HRAS—ovarian cancer	5.26e-05	0.000259	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PPP2R1A—ovarian cancer	5.25e-05	0.000258	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—ovarian cancer	5.24e-05	0.000257	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—ovarian cancer	5.22e-05	0.000256	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CTNNB1—ovarian cancer	5.06e-05	0.000249	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—ovarian cancer	5.03e-05	0.000248	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PIK3CA—ovarian cancer	5.03e-05	0.000247	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—ovarian cancer	5e-05	0.000246	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ovarian cancer	5e-05	0.000246	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK3—ovarian cancer	4.95e-05	0.000243	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PTEN—ovarian cancer	4.93e-05	0.000243	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	4.88e-05	0.00024	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	4.78e-05	0.000235	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	4.77e-05	0.000235	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—ovarian cancer	4.71e-05	0.000232	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK1—ovarian cancer	4.71e-05	0.000232	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—ovarian cancer	4.68e-05	0.00023	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	4.65e-05	0.000229	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—HRAS—ovarian cancer	4.65e-05	0.000229	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—AKT1—ovarian cancer	4.64e-05	0.000228	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—ovarian cancer	4.64e-05	0.000228	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	4.61e-05	0.000227	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MMP2—ovarian cancer	4.59e-05	0.000226	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6ST—ovarian cancer	4.52e-05	0.000222	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—ovarian cancer	4.51e-05	0.000222	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	4.49e-05	0.000221	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—ovarian cancer	4.45e-05	0.000219	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NRAS—ovarian cancer	4.44e-05	0.000218	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HDAC6—ovarian cancer	4.42e-05	0.000217	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NME2—ovarian cancer	4.41e-05	0.000217	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NRAS—ovarian cancer	4.4e-05	0.000216	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—ovarian cancer	4.34e-05	0.000213	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.31e-05	0.000212	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—NRAS—ovarian cancer	4.29e-05	0.000211	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—AKT1—ovarian cancer	4.28e-05	0.00021	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK3—ovarian cancer	4.25e-05	0.000209	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK3—ovarian cancer	4.22e-05	0.000207	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—ovarian cancer	4.14e-05	0.000203	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—ovarian cancer	4.13e-05	0.000203	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MAPK3—ovarian cancer	4.11e-05	0.000202	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—ovarian cancer	4.09e-05	0.000201	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	4.06e-05	0.000199	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK1—ovarian cancer	4.05e-05	0.000199	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—ovarian cancer	4.05e-05	0.000199	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—ovarian cancer	4.02e-05	0.000198	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK1—ovarian cancer	4.01e-05	0.000197	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—ovarian cancer	4.01e-05	0.000197	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDH1—ovarian cancer	3.99e-05	0.000196	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—YAP1—ovarian cancer	3.91e-05	0.000192	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MAPK1—ovarian cancer	3.91e-05	0.000192	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—ovarian cancer	3.91e-05	0.000192	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	3.84e-05	0.000189	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—XIAP—ovarian cancer	3.83e-05	0.000188	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—KRAS—ovarian cancer	3.82e-05	0.000188	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—ovarian cancer	3.82e-05	0.000188	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—ovarian cancer	3.82e-05	0.000188	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PIK3CD—ovarian cancer	3.82e-05	0.000188	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—KRAS—ovarian cancer	3.79e-05	0.000186	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	3.73e-05	0.000184	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMARCA4—ovarian cancer	3.73e-05	0.000184	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KRAS—ovarian cancer	3.69e-05	0.000181	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6ST—ovarian cancer	3.66e-05	0.00018	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	3.65e-05	0.00018	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	3.65e-05	0.00018	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EREG—ovarian cancer	3.64e-05	0.000179	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—ovarian cancer	3.62e-05	0.000178	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—ovarian cancer	3.62e-05	0.000178	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CTNNB1—ovarian cancer	3.52e-05	0.000173	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PIK3CA—ovarian cancer	3.48e-05	0.000171	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	3.45e-05	0.00017	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PGR—ovarian cancer	3.41e-05	0.000168	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NME2—ovarian cancer	3.4e-05	0.000167	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—ovarian cancer	3.4e-05	0.000167	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—ovarian cancer	3.37e-05	0.000166	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MET—ovarian cancer	3.37e-05	0.000166	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—ovarian cancer	3.34e-05	0.000164	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MTOR—ovarian cancer	3.33e-05	0.000164	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PIK3CB—ovarian cancer	3.33e-05	0.000164	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6ST—ovarian cancer	3.3e-05	0.000162	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—ovarian cancer	3.3e-05	0.000162	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDH1—ovarian cancer	3.24e-05	0.000159	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—HRAS—ovarian cancer	3.22e-05	0.000158	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PARP1—ovarian cancer	3.17e-05	0.000156	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	3.17e-05	0.000156	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—HRAS—ovarian cancer	3.14e-05	0.000154	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1B—ovarian cancer	3.12e-05	0.000153	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—ovarian cancer	3.1e-05	0.000152	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PIK3CD—ovarian cancer	3.09e-05	0.000152	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—ovarian cancer	3.08e-05	0.000152	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—STAT3—ovarian cancer	3.07e-05	0.000151	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	3.07e-05	0.000151	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NRAS—ovarian cancer	3.06e-05	0.00015	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—AKT1—ovarian cancer	3.06e-05	0.00015	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—ovarian cancer	3.05e-05	0.00015	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—ovarian cancer	3e-05	0.000148	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CTNNB1—ovarian cancer	2.95e-05	0.000145	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MAPK3—ovarian cancer	2.93e-05	0.000144	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.89e-05	0.000142	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTEN—ovarian cancer	2.87e-05	0.000141	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—AKT1—ovarian cancer	2.87e-05	0.000141	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—AKT1—ovarian cancer	2.84e-05	0.00014	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYTB—ovarian cancer	2.84e-05	0.00014	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP2—ovarian cancer	2.81e-05	0.000138	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MAPK1—ovarian cancer	2.79e-05	0.000137	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—ovarian cancer	2.79e-05	0.000137	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—ovarian cancer	2.73e-05	0.000134	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MTOR—ovarian cancer	2.69e-05	0.000132	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PIK3CB—ovarian cancer	2.69e-05	0.000132	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KRAS—ovarian cancer	2.63e-05	0.00013	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	2.59e-05	0.000127	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PPP2R1A—ovarian cancer	2.57e-05	0.000127	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—STAT3—ovarian cancer	2.57e-05	0.000126	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NRAS—ovarian cancer	2.56e-05	0.000126	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1B—ovarian cancer	2.53e-05	0.000124	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.49e-05	0.000122	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.49e-05	0.000122	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—ovarian cancer	2.47e-05	0.000122	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—ovarian cancer	2.46e-05	0.000121	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK3—ovarian cancer	2.46e-05	0.000121	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTNNB1—ovarian cancer	2.39e-05	0.000117	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.35e-05	0.000116	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK1—ovarian cancer	2.34e-05	0.000115	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—ovarian cancer	2.34e-05	0.000115	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTEN—ovarian cancer	2.33e-05	0.000114	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—HRAS—ovarian cancer	2.24e-05	0.00011	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KRAS—ovarian cancer	2.21e-05	0.000108	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYTB—ovarian cancer	2.19e-05	0.000108	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CTNNB1—ovarian cancer	2.16e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.14e-05	0.000105	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—ovarian cancer	2.14e-05	0.000105	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—ovarian cancer	2.11e-05	0.000104	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT3—ovarian cancer	2.08e-05	0.000102	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NRAS—ovarian cancer	2.08e-05	0.000102	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TERT—ovarian cancer	2.05e-05	0.000101	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PIK3CA—ovarian cancer	2.03e-05	9.97e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK3—ovarian cancer	1.99e-05	9.78e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—AKT1—ovarian cancer	1.98e-05	9.72e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.92e-05	9.43e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.92e-05	9.43e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—ovarian cancer	1.9e-05	9.33e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK1—ovarian cancer	1.89e-05	9.31e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—ovarian cancer	1.89e-05	9.31e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CAV1—ovarian cancer	1.89e-05	9.3e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—STAT3—ovarian cancer	1.88e-05	9.24e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HRAS—ovarian cancer	1.88e-05	9.22e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NRAS—ovarian cancer	1.87e-05	9.21e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ESR1—ovarian cancer	1.82e-05	8.96e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—ovarian cancer	1.8e-05	8.83e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MAPK3—ovarian cancer	1.79e-05	8.82e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6ST—ovarian cancer	1.79e-05	8.82e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KRAS—ovarian cancer	1.79e-05	8.79e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APC—ovarian cancer	1.72e-05	8.47e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CG—ovarian cancer	1.72e-05	8.47e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MAPK1—ovarian cancer	1.71e-05	8.4e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—ovarian cancer	1.71e-05	8.39e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—YAP1—ovarian cancer	1.67e-05	8.19e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AKT1—ovarian cancer	1.66e-05	8.14e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PIK3CA—ovarian cancer	1.64e-05	8.08e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KRAS—ovarian cancer	1.61e-05	7.93e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HRAS—ovarian cancer	1.52e-05	7.47e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CD—ovarian cancer	1.51e-05	7.45e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—ovarian cancer	1.45e-05	7.15e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.4e-05	6.87e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—HRAS—ovarian cancer	1.37e-05	6.74e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FASN—ovarian cancer	1.36e-05	6.68e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AKT1—ovarian cancer	1.34e-05	6.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—ovarian cancer	1.34e-05	6.58e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.34e-05	6.57e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MTOR—ovarian cancer	1.32e-05	6.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CB—ovarian cancer	1.32e-05	6.49e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—ovarian cancer	1.31e-05	6.45e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.29e-05	6.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—YAP1—ovarian cancer	1.29e-05	6.32e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.27e-05	6.26e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—ovarian cancer	1.27e-05	6.24e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1B—ovarian cancer	1.24e-05	6.09e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.24e-05	6.08e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASP3—ovarian cancer	1.21e-05	5.97e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—ovarian cancer	1.21e-05	5.96e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—AKT1—ovarian cancer	1.21e-05	5.95e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCND1—ovarian cancer	1.18e-05	5.81e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CTNNB1—ovarian cancer	1.17e-05	5.76e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTEN—ovarian cancer	1.14e-05	5.61e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.12e-05	5.5e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.1e-05	5.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FASN—ovarian cancer	1.05e-05	5.15e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.03e-05	5.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—ovarian cancer	1.03e-05	5.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT3—ovarian cancer	1.02e-05	5.02e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.02e-05	5.01e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NRAS—ovarian cancer	1.02e-05	5e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TYMS—ovarian cancer	1e-05	4.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC2A1—ovarian cancer	9.96e-06	4.9e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.75e-06	4.79e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK3—ovarian cancer	9.75e-06	4.79e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP1B1—ovarian cancer	9.55e-06	4.69e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—ovarian cancer	9.48e-06	4.66e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK1—ovarian cancer	9.28e-06	4.56e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—ovarian cancer	9.27e-06	4.56e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KRAS—ovarian cancer	8.76e-06	4.31e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	8.47e-06	4.16e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.43e-06	4.14e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CAV1—ovarian cancer	8.07e-06	3.96e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CA—ovarian cancer	8.05e-06	3.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCB1—ovarian cancer	7.86e-06	3.87e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—ovarian cancer	7.79e-06	3.83e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TYMS—ovarian cancer	7.72e-06	3.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HRAS—ovarian cancer	7.45e-06	3.66e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CG—ovarian cancer	7.35e-06	3.61e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—ovarian cancer	7.13e-06	3.5e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKT1—ovarian cancer	6.58e-06	3.23e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CD—ovarian cancer	6.46e-06	3.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CAV1—ovarian cancer	6.22e-06	3.06e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.94e-06	2.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CG—ovarian cancer	5.67e-06	2.79e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.63e-06	2.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CD—ovarian cancer	4.98e-06	2.45e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTEN—ovarian cancer	4.86e-06	2.39e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CB—ovarian cancer	4.34e-06	2.14e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTEN—ovarian cancer	3.75e-06	1.84e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.43e-06	1.69e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—AKT1—ovarian cancer	2.8e-06	1.38e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.65e-06	1.3e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—AKT1—ovarian cancer	2.16e-06	1.06e-05	CbGpPWpGaD
